![Marieke Vermeersch](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Marieke Vermeersch
Plus aucun poste en cours
Profil
Marieke Vermeersch worked as Director-Investor Relations at Ablynx NV in 2013.
Worked as Analyst at Banque Degroof Petercam SA (Private Banking).
Worked as Investor Relations Officer at Perrigo Holding NV.
Worked as VP-Investor Relations & Corporate Communications at Hyloris Pharmaceuticals SA. Worked as Chief Communication Officer at Lakefront Biotherapeutics from 2021 to 2026.
Education includes a graduate degree from Ghent University and an MBA from Solvay Business School of Economics & Management.
Anciens postes connus de Marieke Vermeersch
| Sociétés | Poste | Fin |
|---|---|---|
| LAKEFRONT BIOTHERAPEUTICS NV | Public Communications Contact | 31/03/2026 |
| HYLORIS PHARMACEUTICALS SA | Investor Relations Contact | - |
| OMEGA PHARMA | Public Communications Contact | - |
| ABLYNX | Investor Relations Contact | - |
Banque Degroof Petercam SA (Private Banking)
 Banque Degroof Petercam SA (Private Banking) Investment ManagersFinance Petercam-PB is an active manager with a GARP-oriented investment style. Their investment process relies on in-house fundamental research and combines bottom-up stock selection with top-down macroeconomic considerations. The firm invests a major part of their assets in Eurozone bonds and money-market securities. They also invest significantly in global equity with a strong focus on Europe, and regularly visit the companies in which they invest. They complement their portfolios with global bonds, real estate securities and a limited exposure to alternative investments. | Analyst-Equity | - |
Formation de Marieke Vermeersch
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
41
Relations au 1er degré
7
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 7 |
|---|---|
Galapagos NV
 Galapagos NV BiotechnologyHealth Technology Manufactures and develops pharmaceutical products for oncology | Health Technology |
Banque Degroof Petercam SA (Private Banking)
Banque Degroof Petercam SA (Private Banking) Investment ManagersFinance Petercam-PB is an active manager with a GARP-oriented investment style. Their investment process relies on in-house fundamental research and combines bottom-up stock selection with top-down macroeconomic considerations. The firm invests a major part of their assets in Eurozone bonds and money-market securities. They also invest significantly in global equity with a strong focus on Europe, and regularly visit the companies in which they invest. They complement their portfolios with global bonds, real estate securities and a limited exposure to alternative investments. | Finance |
Omega Pharma NV
 Omega Pharma NV Pharmaceuticals: MajorHealth Technology Manufactures and distributes body care pharmaceutical products, vitamins & supplements | Health Technology |
Ablynx NV
 Ablynx NV BiotechnologyHealth Technology Develops and produces antibodies | Health Technology |
Ghent University
 Ghent University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Solvay Business School of Economics & Management
 Solvay Business School of Economics & Management Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Hyloris Pharmaceuticals SA
 Hyloris Pharmaceuticals SA Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical products by reformulating well-known drugs | Health Technology |
